Two-Months-off, Four-Months-on Antiretroviral Regimen Increases the Risk of Resistance, Compared with Continuous Therapy: A Randomized Trial Involving West African Adults-Reference-Cited by-同舟云学术

Two-Months-off, Four-Months-on Antiretroviral Regimen Increases the Risk of Resistance, Compared with Continuous Therapy: A Randomized Trial Involving West African Adults

Published:2009-01-01 Issue:1 Volume:199 Page:66-76
ISSN:0022-1899
Container-title:Journal of Infectious Diseases
language:en
Short-container-title:J Infect Dis.

Author:

Danel Christine,Moh Raoul,Chaix Marie-Laure,Gabillard Delphine,Gnokoro Joachim,Diby Charles-Joseph,Toni Thomas,Dohoun Lambert,Rouzioux Christine,Bissagnene Emmanuel,Salamon Roger,Anglaret Xavier,

Publisher

Oxford University Press (OUP)

Subject

Infectious Diseases,Immunology and Allergy

Link

http://academic.oup.com/jid/article-pdf/199/1/66/18055952/199-1-66.pdf

Reference37 articles.

1. Pai NP Tulsky JP Lawrence J Colford JM Jr. Reingold AL . Structured treatment interruptions (STI) in chronic suppressed HIV infection in adults. Cochrane Database Syst Rev 2005:CD005482.

2. An evaluation of needle exchange programmes in China

3. The risk of treatment versus the risk of HIV replication

4. Structured Treatment Interruptions: A Risky Business

5. CD4+ cell-count-guided treatment interruptions in chronic HIV-infected patients with good response to highly active antiretroviral therapy;Boschi;AIDS,2004

Cited by 30 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Individual and healthcare supply-related HIV transmission factors in HIV-positive patients enrolled in the antiretroviral treatment access program in the Centre and Littoral regions in Cameroon (ANRS-12288 EVOLCam survey);PLOS ONE;2022-04-06

2. Synthesis and molecular structure of 4-{[6-((2SR,4SR)-4-acetyl-4-methylpyrrolidin-2-yl)-2-(4-cyanophenoxy)pyrimidin-4-yl]oxy}-3,5-dimethylbenzonitrile and 4-[(6-{(2SR,4SR)-4-acetyl-1-[(4-bromophenyl)sulfonyl]-4-methylpyrrolidin-2-yl}-2-(4-cyanophenoxy)pyrimidin-4-yl)oxy]-3,5-dimethylbenzonitrile;Chemistry of Heterocyclic Compounds;2022-01

3. Precore G1896A mutation is associated with reduced rates of HBsAg seroclearance in treated HIV hepatitis B virus co-infected patients from Western Africa;Journal of Viral Hepatitis;2018-05-09

4. CD4+ T Cell Recovery and Hepatitis B Virus Coinfection in HIV-Infected Patients from Côte d'Ivoire Initiating Antiretroviral Therapy;AIDS Research and Human Retroviruses;2018-05

5. Clinical Outcomes during Treatment Interruptions in Human Immunodeficiency Virus–Hepatitis B Virus Co-infected Patients from Sub-Saharan Africa;The American Journal of Tropical Medicine and Hygiene;2017-12-06